Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
This study is currently recruiting participants.
Verified November 2012 by Thrombologic ApS
Sponsor:
Thrombologic ApS
Collaborators:
Anders Perner
Rigshospitalet, Denmark
Information provided by (Responsible Party):
Thrombologic ApS
ClinicalTrials.gov Identifier:
NCT01532544
First received: January 30, 2012
Last updated: November 2, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |